Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov 9;72(12):1676-1682.
doi: 10.1093/gerona/glx075.

Apolipoprotein E4 Allele and Gait Performance in Mild Cognitive Impairment: Results From the Gait and Brain Study

Ryota Sakurai  1   2   3 , Manuel Montero-Odasso  1   2   4
Affiliations

Apolipoprotein E4 Allele and Gait Performance in Mild Cognitive Impairment: Results From the Gait and Brain Study

Ryota Sakurai et al. J Gerontol A Biol Sci Med Sci. .

Abstract

Background: The apolipoprotein E polymorphism ε4 allele (ApoE4) and gait impairment are both known risk factors for developing cognitive decline and dementia. However, it is unclear the interrelationship between these factors, particularly among older adults with mild cognitive impairment (MCI) who are considered as prodromal for Alzheimer's disease. This study aimed to determine whether ApoE4 carrier individuals with MCI may experience greater impairment in gait performance.

Methods: Fifty-six older adults with MCI from the "Gait and Brain Study" who were identified as either ApoE4 carriers (n = 20) or non-ApoE4 carriers (n = 36) with 1 year of follow-up were included. Gait variability, the main outcome variable, was assessed as stride time variability with an electronic walkway. Additional gait variables and cognitive performance (mini-mental state examination [MMSE] and Montreal Cognitive Assessment [MoCA]) were also recorded. Covariates included age, sex, education level, body mass index, and number of comorbidities.

Results: Baseline characteristics were similar for both groups. Repeated measures analysis of covariance showed that gait stride time and stride length variabilities significantly increased in ApoE4 carriers but was maintained in the non-ApoE4 carriers. Similarly, ApoE4 carriers showed greater decrease in MMSE score at follow-up.

Conclusions: In this sample of older adults with MCI, the presence of at least one copy of ApoE4 was associated with the development of both increased gait variability and cognitive decline during 1 year of follow-up. ApoE4 genotype might be considered as a potential mediator of decline in mobility function in MCI; future studies with larger samples are needed to confirm our preliminary findings.

Keywords: Apolipoprotein E; Cognition; Gait variability; Longitudinal study; Mild cognitive impairment.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Comparisons of gait variables at baseline and 1-year follow-up for ApoE4 carriers and non-ApoE4 carriers.
Figure 2.
Figure 2.
Comparisons of cognitive measurements at baseline and 1-year follow-up for ApoE4 carriers and non-ApoE4 carriers.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183–194. doi:10.1111/j.1365-2796.2004.01388.x - PubMed
    1. Montero-Odasso M, Oteng-Amoako A, Speechley M, et al. The motor signature of mild cognitive impairment: results from the gait and brain study. J Gerontol A Biol Sci Med Sci. 2014;69:1415–1421. doi:10.1093/gerona/glu155 - PMC - PubMed
    1. Verghese J, Annweiler C, Ayers E, et al. Motoric cognitive risk syndrome: multicountry prevalence and dementia risk. Neurology. 2014;83:718–726. doi:10.1212/WNL.0000000000000717 - PMC - PubMed
    1. Montero-Odasso MM, Barnes B, Speechley M, et al. Disentangling cognitive-frailty: results from the Gait and Brain Study. J Gerontol A Biol Sci Med Sci. 2016;71:1476–1482. doi:10.1093/gerona/glw044 - PubMed
    1. Muir SW, Speechley M, Wells J, Borrie M, Gopaul K, Montero-Odasso M. Gait assessment in mild cognitive impairment and Alzheimer’s disease: the effect of dual-task challenges across the cognitive spectrum. Gait Posture. 2012;35:96–100. doi:10.1016/j.gaitpost.2011.08.014 - PubMed

Substances